FDA product code QYU: Infant Pulse Rate And Oxygen Saturation Monitor For Over-The-Counter Use

QYU is the FDA product code for infant pulse rate and oxygen saturation monitor for over-the-counter use. It is a Class II device, regulated under 21 CFR 870.2705 and reviewed by the Cardiovascular panel. FDA has cleared 1 510(k) submission under QYU, 1 in the last five years. The average 510(k) review took 135 days (median 135); 135 days on average over the last three years. 1 De Novo request was granted under it.

Definition

An infant pulse rate and oxygen saturation monitor for over-the-counter use is a device that uses photoplethysmography to measure pulse rate and oxygen saturation in infants. The device may contain alarms that alert the caregiver when vital sign(s) go outside preset threshold(s).

Classification

FieldValue
Device nameInfant Pulse Rate And Oxygen Saturation Monitor For Over-The-Counter Use
Device classClass II
Regulation21 CFR 870.2705
Review panelCV — Cardiovascular
Medical specialtyCardiovascular
Premarket route510(k)

510(k) clearances per year for QYU

YearClearancesAvg. review days
20241135

Compare with all 510(k) review times · Search every QYU clearance

Top QYU applicants

ApplicantClearancesLatest
Masimo Corporation12024-05-03

Most recent QYU clearances

510(k)ApplicantDeviceDecision dateReview days
K234021Masimo CorporationMasimo Stork2024-05-03135

Recalls for QYU devices

FDA recall records list no recalls for product code QYU.

Frequently asked questions

What is FDA product code QYU?

QYU is the FDA product code for infant pulse rate and oxygen saturation monitor for over-the-counter use. It is a Class II device, regulated under 21 CFR 870.2705 and reviewed by the Cardiovascular panel.

What device class is QYU?

Class II, regulation 21 CFR 870.2705. Typical premarket route: 510(k).

How long does a 510(k) take for product code QYU?

Across 1 cleared submissions the average was 135 days from receipt to decision (median 135).

Which companies have the most QYU clearances?

Masimo Corporation (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times